DrugPatentWatch Database Preview
« Back to Dashboard
Levofloxacin is a drug marketed by Akorn, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms Ltd, Hospira Inc, Mylan Asi, Zydus Pharms Usa Inc, Anda Repository, Apotex Inc, Mylan Labs Ltd, Watson Labs Teva, Hi Tech Pharma, Lannett Co Inc, Cipla Ltd, Dr Reddys Labs Inc, Glenmark Generics, Hetero Labs Ltd V, Jubilant Generics, Lupin, Macleods Pharms Ltd, Mylan, Orchid Hlthcare, Sandoz, Teva, Torrent Pharms, Watson Labs Inc, Wockhardt, Fresenius Kabi Usa, Hikma Farmaceutica, and Inforlife. and is included in thirty-eight NDAs.
The generic ingredient in LEVOFLOXACIN is levofloxacin. There are thirty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the levofloxacin profile page.